hepatitis B

  • Frontiers of hepatitis B drug development, brief introduction by Dr. altimmune George, prospects of innovative immune drug design

    A new hepatitis B drug heptcell under development by altimmune Pharmaceutical Co., Ltd. was originally scheduled to release phase II data in the second half of this year. At present, the release time of the test data has been postponed to the first half of next year. In a supplementary content published in the second slow hepatitis B drug development summit, Bertrand · Dr. Bertrand Georges continued to introduce the development, design ideas and definition objectives of this candidate drug The frontier of hepatitis B drug development, Dr. altimmune George’s…

    May 24, 2022